Medicare Advantage
Advanced Search

Coverage of Cantharidin (Ycanth) Topical Solution Medicare Advantage Products (Retroactively Effective to 04/01/2024)


Purpose

The purpose of this document is to communicate that the Company has revised its coverage position for cantharidin (Ycanth)​ topical solution.  

The coverage position for cantharidin (Ycanth)​represented by HCPCS code J7354, has been revised from non-covered to medically necessary This medically necessary coverage position is retroactively effective for dates of service beginning 04/01/2024. 

Background

Cantharidin (Ycanth)​ topical solution is approved by the US Food and Drug Administration (FDA) for the treatment of molluscum contagiosum in adult and pediatric individuals ages 2 years and older. ​

Coverage Statement

Cantharidin (Ycanth) topical solution is considered medically necessary and, therefore, covered for the treatment of molluscum contagiosum in adult and pediatric individuals ages 2 years ​and older. Cantharidin (Ycanth)​ topical solution is administered by a professional provider as a single application to each lesion every three weeks as needed, with no more than two applicators used per session.

Coding

J7354Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)​

08/05/2024